Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulsed Field Ablation of Superior Vena Cava in Addition to Pulmonary Vein in Paroxysmal Atrial Fibrillation: A Multicenter Randomized Controlled Trial (PASPA Study)

NCT07191626 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT07191626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulsed Field Ablation of Superior Vena Cava in Addition to Pulmonary Vein in Paroxysmal Atrial Fibrillation: A Multicenter Randomized Controlled Trial (PASPA Study)
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
November 1, 2027
Enrollment
650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation, paroxysmal atrial fibrillation (paf)